placeholder

F-star Therapeutics Reports Full-Year 2020 Financial Results and Provides Corporate Update

01/04/2021

F-star Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, today announces 2020 full-year financial results and provides corporate update.

Click here to read more.